These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 8887307

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hormone replacement therapy and lipid-lipoprotein concentrations.
    Gökmen O, Yapar Eyi EG.
    Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):31-41. PubMed ID: 10428319
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A, Aldemir DA, Bayrak T, Corakçi A, Dursun P.
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [Abstract] [Full Text] [Related]

  • 8. Effects of estrogen and medroxyprogesterone acetate on subpopulations of triglyceride-rich lipoproteins and high-density lipoproteins.
    Lamon-Fava S, Posfai B, Asztalos BF, Horvath KV, Dallal GE, Schaefer EJ.
    Metabolism; 2003 Oct; 52(10):1330-6. PubMed ID: 14564686
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of conjugated estrogens with and without medrogestone: a prospective study.
    van der Mooren MJ, Leuven JA, Rolland R.
    Maturitas; 1994 May; 19(1):33-42. PubMed ID: 7935030
    [Abstract] [Full Text] [Related]

  • 16. Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group.
    Pickar JH, Wild RA, Walsh B, Hirvonen E, Lobo RA.
    Climacteric; 1998 Mar; 1(1):26-32. PubMed ID: 11913407
    [Abstract] [Full Text] [Related]

  • 17. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
    Tilly-Kiesi M, Kahri J, Pyörälä T, Puolakka J, Luotola H, Lappi M, Lahdenperä S, Taskinen MR.
    Atherosclerosis; 1997 Mar 21; 129(2):249-59. PubMed ID: 9105568
    [Abstract] [Full Text] [Related]

  • 18. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Baracat EC, Barbosa IC, Giordano MG, Haidar MA, Marinho RM, Menegocci JC, Morais KM, Tomaz G, Wehba S.
    Climacteric; 2002 Mar 21; 5(1):60-9. PubMed ID: 11974560
    [Abstract] [Full Text] [Related]

  • 19. Distinct lipid/lipoprotein profiles and hormonal responsiveness in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
    Taechakraichana N, Holinka CF, Haines CJ, Subramaniam R, Tian XW, Ausmanas MK.
    Climacteric; 2007 Jun 21; 10(3):225-37. PubMed ID: 17487649
    [Abstract] [Full Text] [Related]

  • 20. The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.
    Gevers Leuven JA, van der Mooren MJ, Buytenhek R.
    Fertil Steril; 1995 Sep 21; 64(3):525-31. PubMed ID: 7641905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.